215 related articles for article (PubMed ID: 14704147)
1. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
2. A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation.
Miyoshi N; Uchida K; Osawa T; Nakamura Y
Cancer Res; 2004 Mar; 64(6):2134-42. PubMed ID: 15026354
[TBL] [Abstract][Full Text] [Related]
3. Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade.
Fan M; Goodwin M; Vu T; Brantley-Finley C; Gaarde WA; Chambers TC
J Biol Chem; 2000 Sep; 275(39):29980-5. PubMed ID: 10913135
[TBL] [Abstract][Full Text] [Related]
4. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
5. Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.
Jacobs-Helber SM; Sawyer ST
Blood; 2004 Aug; 104(3):696-703. PubMed ID: 15059850
[TBL] [Abstract][Full Text] [Related]
6. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia.
Okuno S; Saito A; Hayashi T; Chan PH
J Neurosci; 2004 Sep; 24(36):7879-87. PubMed ID: 15356200
[TBL] [Abstract][Full Text] [Related]
7. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
8. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
[TBL] [Abstract][Full Text] [Related]
9. Involvement of stress-activated protein kinase/c-Jun N-terminal kinase in endothelin-1-induced heat shock protein 27 in osteoblasts.
Tokuda H; Niwa M; Ito H; Oiso Y; Kato K; Kozawa O
Eur J Endocrinol; 2003 Sep; 149(3):239-45. PubMed ID: 12943527
[TBL] [Abstract][Full Text] [Related]
10. Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells.
Miyamoto-Yamasaki Y; Yamasaki M; Tachibana H; Yamada K
Cell Biol Int; 2007 Dec; 31(12):1501-6. PubMed ID: 17904874
[TBL] [Abstract][Full Text] [Related]
11. Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation.
Figueroa-Masot XA; Hetman M; Higgins MJ; Kokot N; Xia Z
J Neurosci; 2001 Jul; 21(13):4657-67. PubMed ID: 11425893
[TBL] [Abstract][Full Text] [Related]
12. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
13. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
[TBL] [Abstract][Full Text] [Related]
14. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells.
Mingo-Sion AM; Marietta PM; Koller E; Wolf DM; Van Den Berg CL
Oncogene; 2004 Jan; 23(2):596-604. PubMed ID: 14724588
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis.
Vantieghem A; Xu Y; Assefa Z; Piette J; Vandenheede JR; Merlevede W; De Witte PA; Agostinis P
J Biol Chem; 2002 Oct; 277(40):37718-31. PubMed ID: 12101183
[TBL] [Abstract][Full Text] [Related]
18. Basal c-Jun N-terminal kinases promote mitotic progression through histone H3 phosphorylation.
Lee K; Song K
Cell Cycle; 2008 Jan; 7(2):216-21. PubMed ID: 18256527
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways.
Guan QH; Pei DS; Zhang QG; Hao ZB; Xu TL; Zhang GY
Brain Res; 2005 Feb; 1035(1):51-9. PubMed ID: 15713276
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
